Liver Diseases  >>  GS-0938  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GS-0938 / Gilead
QUANTUM, NCT01435044: Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

Checkmark EASL 2013: QUANTUM
Apr 2013 - Apr 2013: EASL 2013: QUANTUM
Checkmark QUANTUM
Apr 2012 - Apr 2012: QUANTUM
Completed
2
239
US
Sofosbuvir, Sovaldi™, GS-7977, PSI-7977, GS-0938, PSI-352938, RBV, Ribasphere®, Placebo to match sofosbuvir, Placebo to match GS-0938
Gilead Sciences, Quintiles, Inc.
Hepatitis C, Chronic
04/13
05/13

Download Options